At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
study of osteofibrous dysplasia featuresbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Osteofibrous Dysplasia (Kempson-Campanacci's Disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship With Adamantinoma
In Brief
An observational study evaluating study of osteofibrous dysplasia features for Osteofibrous Dysplasia. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOsteofibrous Dysplasia
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedSep 2019
Primary CompletionNov 2019
Study CompletionSep 2021
TodayJul 2026
First PostedSep 26, 2019
Enrollment StartAug 8, 2019
Primary CompletionNov 30, 2019
Study CompletionSep 30, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.8 years ago
Interventions
study of osteofibrous dysplasia featuresbehavioral
obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.